Search research articles
Contact Us
Filters
Showing results (531-540 of 562) with videos related to
Page
of 57
Sort By:
JAMA Network Open
|
January 16, 2019
Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
Eric D Brooks, Bing Sun, Lei Feng, et al.
JAMA Oncology
|
July 21, 2017
Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study
Joe Y Chang, Vivek Verma, Ming Li, et al.
Nature Immunology
|
November 24, 2020
MEK inhibition reprograms CD8<sup>+</sup> T lymphocytes into memory stem cells with potent antitumor effects
Vivek Verma, Nazli Jafarzadeh, Shannon Boi, et al.
Oncotarget
|
April 21, 2017
Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells
Muzafar A Macha, Satyanarayana Rachagani, Asif Khurshid Qazi, et al.
Journal of Radiosurgery and SBRT
|
August 18, 2020
Multi-institutional retrospective review of stereotactic radiosurgery for brain metastasis in patients with small cell lung cancer without prior brain-directed radiotherapy
Joseph A Miccio, Andrew Barsky, Sarah Gao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials
Dario Pasalic, Gwendolyn J McGinnis, C David Fuller, et al.
Journal for Immunotherapy of Cancer
|
October 6, 2025
Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial
Maliazurina B Saad, Eman Showkatian, Vivek Verma, et al.
Science Translational Medicine
|
May 11, 2022
Acute inflammatory response via neutrophil activation protects against the development of chronic pain
Marc Parisien, Lucas V Lima, Concetta Dagostino, et al.
Journal of the National Cancer Institute
|
July 28, 2019
Sex-Based Disparities Among Cancer Clinical Trial Participants
Ethan B Ludmir, C David Fuller, Shalini Moningi, et al.
Journal for Immunotherapy of Cancer
|
September 6, 2019
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy
Hari Menon, Dawei Chen, Rishab Ramapriyan, et al.
Page
of 57
Search research articles
Search
Showing results (531-540 of 562) with videos related to
Sort By:
Page
of 57
JAMA Network Open
|
January 16, 2019
Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
Eric D Brooks, Bing Sun, Lei Feng, et al.
JAMA Oncology
|
July 21, 2017
Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study
Joe Y Chang, Vivek Verma, Ming Li, et al.
Nature Immunology
|
November 24, 2020
MEK inhibition reprograms CD8<sup>+</sup> T lymphocytes into memory stem cells with potent antitumor effects
Vivek Verma, Nazli Jafarzadeh, Shannon Boi, et al.
Oncotarget
|
April 21, 2017
Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells
Muzafar A Macha, Satyanarayana Rachagani, Asif Khurshid Qazi, et al.
Journal of Radiosurgery and SBRT
|
August 18, 2020
Multi-institutional retrospective review of stereotactic radiosurgery for brain metastasis in patients with small cell lung cancer without prior brain-directed radiotherapy
Joseph A Miccio, Andrew Barsky, Sarah Gao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials
Dario Pasalic, Gwendolyn J McGinnis, C David Fuller, et al.
Journal for Immunotherapy of Cancer
|
October 6, 2025
Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial
Maliazurina B Saad, Eman Showkatian, Vivek Verma, et al.
Science Translational Medicine
|
May 11, 2022
Acute inflammatory response via neutrophil activation protects against the development of chronic pain
Marc Parisien, Lucas V Lima, Concetta Dagostino, et al.
Journal of the National Cancer Institute
|
July 28, 2019
Sex-Based Disparities Among Cancer Clinical Trial Participants
Ethan B Ludmir, C David Fuller, Shalini Moningi, et al.
Journal for Immunotherapy of Cancer
|
September 6, 2019
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy
Hari Menon, Dawei Chen, Rishab Ramapriyan, et al.
Page
of 57